🇺🇸

US SEC Filing Intelligence

Daily AI-powered analysis of SEC EDGAR filings, FDA approvals, and US regulatory disclosures. Investment signals, risk flags, and sector themes for US markets.

·daily

S&P 500 Financials Sector SEC Filings — April 06, 2026

Across 50 filings in the USA S&P 500 Financials intelligence stream (despite some cross-sector inclusions), dominant themes include a surge in proxy materials for May 2026 annual meetings (e.g., Schwab, MAA, Genworth, JPM), signaling routine governance but with positive comp approvals; robust M&A activity (Neurocrine-Soleno $2.9B, Profusa LOI $30M stock); mixed financial trends with JPM's record $185.6B revenue/17% ROE contrasting Airsculpt's -15.8% YoY revenue drop to $151.8M and widened net loss to -$11.7M; SPAC/IPO filings highlighting dilution risks. Period-over-period, 4/10 with revenue data show declines averaging -12% YoY (Airsculpt -15.8%, Laird +24% outlier), while JPM/Middlesex post strong growth; capital allocation leans to dividends (Middlesex 53-year streak) and buybacks absent. Forward-looking catalysts cluster in May meetings and Q2 deals, with guidance stable/positive (Airsculpt FY26 $151-157M revenue). Portfolio implication: Financials like JPM/Schwab exhibit strength amid sector proxy normalization, but watch M&A dilution and revenue softness in adjacent names.

25 high priority25 medium50 total filings
·daily

S&P 500 Consumer Staples Sector SEC Filings — April 06, 2026

Across 40 SEC filings in the USA S&P 500 Consumer Staples intelligence stream (encompassing food/beverage like Krispy Kreme/McCormick alongside broader market filings), key themes include widespread board refreshments and leadership transitions (12+ instances, e.g., Krispy Kreme adding Kraft Heinz alum, Tapestry Pinterest CTO), accelerating M&A (McCormick-Unilever SpinCo tax-free merger, Clear Channel Mubadala-backed deal), and mixed financial trends with average reported revenue growth of +5.8% YoY (iQSTEL +11.9% to $317M, NewtekOne volumes +7% implied, offset by Tsakos -0.7%, Elvictor +0.3%). Margin trends show slight improvement where noted (iQSTEL gross +72bps to 3.46%), but op ex pressures (Elvictor +19%). Forward-looking data clusters catalysts in late April-May 2026 (10+ AGMs/earnings). No major insider buys/sells, but separations (Krispy CPO, DeFi CCO) and capital allocation via share issuances/dilutive debt amendments (Bright Mountain 2.9M shares). Sentiment positive/neutral in 70%, mixed in 25%; actionable: Buy growth catalysts like NewtekOne, avoid debt restructurings. Portfolio implication: Staples governance strengthening amid modest growth, M&A upside for McCormick.

16 high priority24 medium40 total filings
·daily

S&P 500 Industrials Sector SEC Filings — April 06, 2026

Across 50 SEC filings from the USA S&P 500 Industrials stream (broadly including aerospace, machinery, and adjacent sectors), proxy statements dominate (over 60% of filings) signaling peak proxy season with clustered 2026 AGMs in mid-May, featuring director elections, say-on-pay, auditor ratifications, and equity plans amid mixed shareholder support (e.g., NioCorp's LTIP saw 5.3M against votes). Period-over-period trends reveal selective growth in industrials like Howmet Aerospace (sales +11.1% YoY to $8.25B, EBITDA +26.2%) and Integer Holdings (sales +8% YoY to $1.85B, adj EPS +21%), contrasted by energy headwinds (Phillips 66 Q1 MTM losses ~$900M) and deteriorations (Shepherd's net income -19% YoY, Nutra Pharma net loss -47.8% worse YoY despite sales +22.4%). Forward-looking catalysts include Q1 impacts (Biogen $34M IPRD expense hit EPS $0.19, Enphase GAAP margin -6.7pts from tax credit sale), M&A (Legence $427M Bowers acquisition boosting pro forma revenue to $3.45B), and capital actions (Horace Mann $57M returns via dividends/buybacks). Portfolio-level patterns show capital allocation favoring shareholder returns and tuck-ins, but rising expenses/expenses pressures in 7/15 quantified filings average margin hits of -150bps where noted; implications favor monitoring aerospace outperformance vs energy volatility for tactical positioning ahead of May catalysts.

27 high priority23 medium50 total filings
·daily

S&P 500 Energy Sector SEC Filings — April 06, 2026

Across 10 filings in the S&P 500 Energy stream (with some cross-sector context), proxy season kicks off with 7 DEF/DEFA14A filings highlighting annual meetings in May 2026, mixed executive comp performance (e.g., MAA beat Core FFO $8.77 vs $8.74 target but missed SS NOI -1.36% vs -1.15% and 3-yr TSR -1.47% vs 4.07%), and neutral governance updates. Energy pure-plays show divergence: Phillips 66 (PSX) flags severe Q1 2026 MTM losses of $900M across Refining ($350-450M), Marketing ($300-400M), and Renewables ($100-200M) due to commodity spikes and $3B collateral outflow, offset by strong Midstream $550-600M; Cheniere Energy (LNG) and Partners (CQP) signal leadership stability via transitions/appointments effective April-May 2026. Limited YoY/QoQ trends include MAA audit fees -13% to $2.48M and Copper CTL $0.081/unit distribution payable Apr 10; no broad insider selling/buying or M&A. Portfolio-level: Refining volatility pressures margins/debt (PSX net debt $22B, target $17B by 2027), while LNG/governance steady; implications include near-term refining downside risk but May catalysts for comp votes and board refresh.

4 high priority6 medium10 total filings
·daily

Dow Jones 30 Stocks SEC Filings — April 06, 2026

Across 50 SEC filings from Dow Jones 30 constituents and related entities on April 6, 2026, dominant themes include a surge in proxy materials (25+ DEF/DEFA14A filings) signaling peak annual meeting season in May 2026, with votes on directors, compensation, auditors, and equity plans; ongoing M&A and SPAC activity (Clear Channel merger, Inflection Point IPO, Spring Valley combo); leadership transitions (TVA CEO retirement, Veradigm CFO appointment, Cisco/Verizon board shifts); and debt restructurings/amendments (Clear Channel consents, Mativ Ninth Amendment, Honest Co. First Amendment). Period-over-period trends are sparse but highlight improvements like Horace Mann's core earnings up YoY to $195.8M (ROE +300bps to 12.4%), Madison Air operating cash flows +118% YoY to $480M, and Strategic Acquisitions net loss narrowed 67% YoY to $40k, contrasted by revenue drops (Strategic to $0) and cash plunges (-98%). Capital allocation shows shareholder returns (Horace Mann $57M divs/buybacks), equity grants (Oxbridge Re NEOs), and high debt service burdens (Madison Air 68% of cash flows). Positive regulatory tailwinds for digital assets (Evernorth XRP clarity) and fusion tech (Spring Valley) emerge, but risks from merger delays, financial strains (MSP Recovery advances), and control weaknesses (Madison Air) loom. Portfolio implications favor monitoring DJ30 names like JPM (record $185.6B revenue), Verizon/Cisco board changes for governance signals, with alpha in M&A catalysts amid neutral-to-mixed sentiment (60% neutral).

29 high priority21 medium50 total filings
·daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 06, 2026

Across 50 filings from the S&P 500 Consumer Discretionary stream (with cross-sector influences from financials and REITs impacting retail/auto/entertainment), proxy season dominates with 25+ DEF 14A/DEFA14A filings highlighting board refreshes (e.g., 50% new independents at Principal Financial), auditor ratifications, and stock incentive plan approvals signaling governance strength and capital allocation toward equity comp. M&A/divestiture activity is robust, including Profusa's $30M PanOmics LOI (closing by June 2026), Aptiv's Versigent spin-off (April 1, 2026), Six Flags' sale of 6 parks (April 6, 2026), and Laird Superfood's acquisition showing 24% YoY sales growth to $45.3M with net income turnaround to $1.6M. Where period comparisons exist, trends show revenue growth (avg +20% YoY in 3 cases) but mixed cash positions (e.g., Laird cash down to $0.16M). Leadership changes (e.g., Veradigm permanent CFO, Mawson board overhaul) indicate strategic pivots, while funding deals like PacifiCorp's $2.55B LC and Goldman Sachs indenture support expansion. Portfolio-level, positive sentiment in 12/50 (24%) vs mixed/neutral, with May 2026 overloaded with 20+ annual meetings as key catalysts; actionable theme is governance-driven stability amid M&A for consumer firms.

30 high priority20 medium50 total filings
·daily

S&P 500 Healthcare Sector SEC Filings — April 06, 2026

Across 49 filings dominated by proxy statements (over 20 DEF14A/DEFA14A/PREM14A for May 2026 AGMs), the S&P 500 Healthcare stream reveals accelerating M&A and clinical momentum amid routine governance, with Neurocrine Biosciences (NBIX) announcing a $2.9B acquisition of Soleno Therapeutics adding $190M 2025 revenue from VYKAT XR. Period-over-period trends show mixed results: Elvictor Group revenue +0.3% YoY but net loss swing to -$175k (EPS -$0.21 from +$0.24), NewtekOne loan originations +40% YoY to 961 units/$391M in Q1 2026, and Biogen flagging $34M Q1 IPR&D expenses (-$0.19 EPS). Biotech highlights include Praxis Precision Medicines' 77% placebo-adjusted seizure reduction in EMBRAVE trial and FDA priority review for relutrigine (PDUFA Sep 27, 2026). Portfolio-level patterns indicate positive capital deployment via acquisitions/deals (NBIX, ProCap, Six Flags divestiture) and stable guidance (NewtekOne Q1 EPS $0.37-0.47), but expense pressures in pharma; healthcare M&A premiums average ~42% (NBIX 34-51%). Actionable now: monitor May AGMs for comp/share approvals, NBIX close in 90 days.

24 high priority25 medium49 total filings
·daily

S&P 500 Technology Sector SEC Filings — April 03, 2026

Across the 7 filings in the S&P 500 Technology stream (though skewed toward small-cap biotech, financials, and niche players), dominant themes include proxy statements for upcoming annual meetings (Aditxt, Camden), leadership compensation updates (Radian), auditor changes (Arcadia), shelf registrations for resale (Lyell), institutional portfolios (Adirondack), and stark financial deterioration (Token). Period-over-period trends reveal acute weakness in Token Communities with revenues plunging 85% YoY to $356k, gross margins collapsing 98% to $18k, and net loss of $464k vs prior profit, contrasting neutral stability elsewhere; no broad tech margin compression or growth patterns emerge due to diverse/non-core filers. Critical developments include Arcadia's auditor dismissal amid going concern warnings and material control weaknesses, signaling distress in ag-biosciences, while Aditxt's reverse split authorization flags liquidity risks. Portfolio-level patterns show proxy season catalysts in May 2026, limited insider conviction (none reported), and Adirondack's heavy tech exposure (Apple, Amazon). Market implications: Low conviction for tech longs, heightened risks in small caps, monitor governance votes for alpha.

3 high priority4 medium7 total filings
·daily

Nasdaq 100 Stocks SEC Filings — April 03, 2026

Proxy season is accelerating across NASDAQ-100 related filings with four companies (Mondelez, Aditxt, Camden National, Radian implied via comp) scheduling virtual annual meetings in May 2026, focusing on director elections, say-on-pay, auditor ratifications, and reverse splits. Period-over-period trends reveal stark contrasts: Token Communities suffered an 85% YoY revenue plunge to $356k, 87% drop in home sales, and gross margins shriveled 98% to $18k, while Mondelez reported solid 2025 net revenue growth and strong FCF amid cocoa volatility. Exec transitions signal caution—Intel's EVP/Chief Legal Officer exit effective June 1, 2026 (negative), contrasted by Radian's new Interim CFO compensation package ($500k base, $1M LTIP). Arcadia Biosciences' auditor switch highlights ongoing distress with going concern warnings and material control weaknesses from Dec 31, 2025 10-K. Lyell's S-3 enables resale of 1.95M shares from $25.61 milestone pricing (premium to $13.32 initial), potentially pressuring supply. Overall themes: resilient consumer staples (MDLZ) vs. biotech/small-cap distress (ADTX, LYEL, RKDA, TKCM), with limited capital allocation or insider trading signals but high event density for catalysts.

5 high priority5 medium10 total filings
·daily

S&P 500 Financials Sector SEC Filings — April 03, 2026

Across 50 SEC filings from the USA S&P 500 Financials stream (though including diverse sectors), overarching themes include a heavy proxy season with 15+ annual/special meetings clustered in May 2026 (e.g., Valley National Bancorp May 18, Certara May 14), signaling routine governance but potential shareholder activism risks. Period-over-period trends reveal polarized performance: 6/12 companies with financial metrics showed YoY revenue growth averaging +22% (EACO +17.7%, Karman +36.6%), but margins mixed with compressions (Karman -290bps operating) and income declines (TCW Direct Lending -44% investment income); lending firms like TCW and Generation Income reported widening losses amid higher expenses. Forward-looking catalysts abound in April-May 2026: tender offer extensions (Lisata to Apr 13), spin-offs (First Tracks Apr 20), M&A approvals (Prosperity Bancshares-Stellar, European Wax going-private May 7), and Nasdaq hearings (Aeries, Twin Vee by Apr 9). Capital allocation highlights shareholder returns (GE Vernova doubled dividend to $2/share, +$3.6B buybacks/repurchases) contrasting debt stresses (Atlantic International defaults, United Homes covenant waivers). Insider activity sparse but neutral (no buys/sells flagged); sentiment mixed/neutral dominant (28/50 neutral), with financials like Valley National, Radian Group, FIS showing stable governance. Portfolio implications: overweight growth outliers like EACO/Karman, monitor delisting risks in small caps, and position for M&A catalysts in banks/insurers.

23 high priority27 medium50 total filings
·daily

S&P 500 Consumer Staples Sector SEC Filings — April 03, 2026

Across 50 filings in the USA S&P 500 Consumer Staples stream (with broader context), proxy season dominates with 20+ DEF/DEFA14A filings signaling annual meetings in May 2026, highlighting mixed 2025 performance: solid adjusted metrics (e.g., Kraft Heinz adj EPS $2.60, Mondelez >$3B FCF target) amid GAAP challenges and cocoa volatility. Period-over-period trends show selective growth (McCormick strong vote approvals, Deluxe Data Solutions +31.3% YoY) but declines in others (Elventix cash -64.4%, Print -5.7%). Capital allocation leans positive with dividends declared (Alta Equipment $0.625/DS) and redemptions (Moog 2027 notes). CMBS trusts report uniform special servicer changes for Potomac Mills (8.9%-2.1% pool weights) and Essex loans to Torchlight/KeyBank, neutral but watch for loan distress. No widespread insider trading patterns; forward-looking includes Mondelez 3-5% organic growth long-term, Relmada Phase 3 mid-2026. Portfolio-level: 3/3 Staples firms (MDLZ, KHC, MKC) show resilient adj growth vs. sector headwinds, but mixed sentiment prevails. Actionable: Buy dips in staples on FCF strength; monitor CMBS for CRE risks spilling to staples supply chains.

24 high priority26 medium50 total filings
·daily

S&P 500 Industrials Sector SEC Filings — April 03, 2026

Across 50 filings in the USA S&P 500 Industrials stream (with some cross-sector context), proxy season dominates with 20+ DEF/DEFA14A filings highlighting robust 2025 performance in key industrials like GE Vernova (revenue +9% YoY to $38B, backlog $150B) and ITT Inc. (revenue +8% YoY to $3.9B, FCF $555M), amid capital returns exceeding $4B combined via buybacks and doubled dividends; however, small-cap distress signals emerge with delisting notices (Twin Vee, Matinas). Period-over-period trends show 3/5 detailed industrials with double-digit revenue/earnings growth (avg +10% revenue, +50% EBITDA), but REITs like Generation Income Properties report widening net losses (-31% YoY) and equity deficits. M&A activity accelerates (ITT's $4.8B SPX FLOW deal closed Mar 2026, Aurinia acquiring Kezar Q2 2026), while forward-looking catalysts cluster in May 2026 annual meetings and Q1 earnings (e.g., SouthState Apr 23). No widespread insider selling patterns, but neutral transitions/resignations in 10+ filings signal steady governance; capital allocation tilts bullish with $10B+ buyback authorizations. Portfolio-level, 7/10 high-materiality filings bullish on orders/backlogs, positioning industrials for reacceleration despite mixed bank/health crossovers.

26 high priority24 medium50 total filings
·daily

S&P 500 Energy Sector SEC Filings — April 03, 2026

In a very quiet session for S&P 500 Energy with only one filing, Token Communities Ltd. (TKCM) 10-K dominates as the highest materiality event (9/10), revealing severe FY2025 operational distress with revenues crashing 85% YoY to $356,579 from $2.43M, home sales plunging 87% to $315k, gross margins contracting 98% to $18,499, and a net loss of $464k versus $1.28M profit prior year. Counterbalancing trends include total assets expanding 51% YoY to $6.04M, inventory surging 47% to $5.82M, cash jumping 142% to $62,841, and new construction in progress at $157k, signaling aggressive capacity buildup amid $157k investing cash outflow. Liabilities climbed 29% to $11.24M with a fresh $3.17M construction loan, widening the stockholders' deficit 10% to $5.20M from $4.74M, while shares outstanding held steady at 2.10B. Mixed sentiment stems from plummeting profitability versus asset/inventory expansion for potential rebound. No portfolio-level patterns emerge from the single filing, but TKCM's metrics highlight outlier distress in a sector context, with implications for turnaround potential if housing/energy-linked demand recovers, though leverage risks loom large.

1 high priority1 total filings
·daily

Dow Jones 30 Stocks SEC Filings — April 03, 2026

Across 50 SEC filings from the USA Dow Jones 30 intelligence stream (with broader coverage including related small/mid-caps and SPACs), overarching themes include intense proxy season preparations for May 2026 annual meetings (15+ filings like GEV, BAC, Valley, EVgo), robust blue-chip growth (GE Vernova +9% YoY revenue to $38B, +213% net income to $4.9B; Bank of America +13% NI to $30.5B, +7% revenue to $113.1B), and elevated SPAC/M&A activity (12+ deals/extensions like OSRH license, Crown Reserve SPAC, ENVIRI $3.04B sale). Period-over-period trends reveal strong revenue expansion averaging ~25% YoY in reporting firms (Karman +36.6% to $471.5M, GEV +9%, BofA +7%) but mixed margins (Karman -290bps to 15.5%, NeOnc Q4 net loss +422% to $62.1M) and cash flow swings (Karman op cash -$22M vs +$26M YoY). Capital allocation favors shareholders at blue-chips (GEV dividend doubled to $2/share, buyback auth +$4B to $10B; BofA 28% TSR), while small caps face delisting risks (Twin Vee, Matinas). Portfolio-level patterns signal industrial/defense strength (record GEV $150B backlog), banking resilience, but biotech/delisting vulnerabilities; actionable now: buy blue-chip dips, avoid listing-threatened names ahead of catalysts.

33 high priority17 medium50 total filings
·daily

S&P 500 Consumer Discretionary Sector SEC Filings — April 03, 2026

Across 50 filings in the USA S&P 500 Consumer Discretionary intelligence stream (though spanning broader sectors via 13Fs and trusts), dominant themes include a surge in proxy statements (15+ filings) for annual/special meetings in May-June 2026 focused on director elections, compensation votes, and auditor ratifications, signaling peak governance season. Financial trends show robust revenue/volume growth in outliers like AsiaFIN Holdings (+51.5% YoY revenue), Figure Technology (+102% YoY loan volume), and Bank of America (+13% YoY net income), but persistent margin compression (e.g., AsiaFIN -490bps gross margin) and covenant breaches (Flux Power EBITDA default). Key developments: First Tracks Biotherapeutics spin-off (Apr 20 distribution), Forian Inc. take-private at 22.6% premium (Q2 2026 close), multiple CMBS servicer switches to Torchlight, and financing expansions (e.g., Blue Owl $100M revolver). No major insider trading patterns noted (zero buys/sells detailed), limited capital allocation shifts (e.g., AFG $707M returns), and neutral sentiment overall (70% filings). Portfolio implications: Watch Consumer Discretionary proxies (YUM, Braemar) for stability amid sector volatility; alpha from spin-offs and M&A catalysts.

29 high priority21 medium50 total filings
·daily

S&P 500 Healthcare Sector SEC Filings — April 03, 2026

Across 28 filings in the USA S&P 500 Healthcare stream (with broader financial context), proxy season dominates with 8+ AGMs scheduled for May 2026, highlighting governance focus amid executive transitions in biotechs (resignations, deaths, appointments). Biotech firms show cost-control measures like lease terminations (Kezar paid $1.3M fee), option repricings (Skye for 2.4M shares at $0.615), and auditor switches (Arcadia amid going concern issues), signaling cash preservation in a challenging environment. AbbVie slashed 2026 adj EPS guidance by $0.41 to $13.96-$14.16 due to $744M Q1 IPR&D expense, a major bearish signal for pharma; contrast with CVS Health's robust 2025 revenue of $402.1B and $10.6B op cash flow. Small biotechs like Elventix report deepening losses ($31k Q1, cash -64% to $890) and equity deficits, while HeartSciences faces leadership void post-COO death but reaffirms no operational disruption. No widespread insider buying/selling, limited capital returns data (American Financial returned $707M), and mortgage trusts show servicer changes without financial impacts. Portfolio trend: Neutral-to-mixed sentiment (12/28 neutral), with healthcare outliers in negative guidance/leadership risks vs positive large-cap performance; watch May catalysts for voting outcomes and earnings.

12 high priority16 medium28 total filings
·daily

S&P 500 Technology Sector SEC Filings — April 02, 2026

The 22 filings from USA S&P 500 Technology stream (April 2, 2026) are dominated by 10 proxy-related documents (DEF 14A/DEFA14A) for May 2026 AGMs, reflecting routine governance with neutral sentiment across NCS Multistage, Iridium, Radian Group, Apple Hospitality REIT, and Community Health Systems; no major disputes or declines noted. Executive transitions in 5 companies (Optimum Communications EVP demotion/retirement with $3.6M payout, Zoom COO resignation May 8, Broadcom CFO retirement Jun 12 with Alphabet CAO successor, Esquire director health-related exit, CareView ongoing debt amendments) are neutral, signaling stable leadership changes without disagreements. Positive financing and operational highlights include ISQ Open Infrastructure's $28.3M unregistered equity raise and $0.34/share distribution (May 5), Immunic's Phase 3 enrollment completion (2,221 patients, topline end-2026), CHS's 2025 net income turnaround to $509M from -$516M loss despite -1.2% YoY revenue to $12.5B, $3.3B debt reduction, and Aditxt Nasdaq compliance confirmation ($4M equity). Apple Hospitality reported 2025 buybacks of 5M shares, hotel portfolio optimization across 84 markets. Portfolio-level trends show sparse but improving financials (e.g., CHS EBITDA margin flat 12.2%, positive FCF), capital returns via buybacks/debt paydown/distributions, and catalysts like biotech data; implications favor monitoring leadership stability and May events amid low volatility.

12 high priority10 medium22 total filings
·daily

Nasdaq 100 Stocks SEC Filings — April 02, 2026

Across 26 NASDAQ-100 related SEC filings dated April 2, 2026, dominant themes include a surge in proxy statements (10+ DEF/DEFA14A) signaling the onset of 2026 proxy season with clustered annual meetings in May, alongside notable executive transitions at tech leaders like Zoom (COO resignation), Alphabet (controller resignation), Broadcom (CFO retirement with Alphabet alum appointment), and Booking Holdings (new CAO). Financial highlights reveal mixed performance: Community Health Systems achieved a dramatic net income turnaround to +$509M from -$516M loss YoY despite -1.2% revenue decline, Trilogy Metals saw Q1 FY2026 loss double to $7.1M YoY amid higher expenses, Tesla reported flat +1% YoY Q1 vehicle deliveries at 358K, and Starbucks closed a positive China JV ceding 60% control for liquidity. Positive catalysts include Immunic's Phase 3 enrollment completion with topline data by end-2026, Booking's 25-for-1 stock split, and Aditxt's Nasdaq compliance resolution. Portfolio-level trends show neutral-to-positive sentiment (8 positive, 12 neutral, 4 mixed, 2 bearish implied), with healthcare/mining outliers in deteriorating losses/revenues but debt reductions/buybacks signaling capital discipline; no broad margin compression evident but limited QoQ/YOY data (e.g., Trilogy cash -7.4% QoQ, CYH EBITDA margin flat 12.2%). Implications favor monitoring May proxy votes for equity plans/governance and Q1 earnings catalysts like Tesla's April 22 webcast for deeper financials.

15 high priority11 medium26 total filings
·daily

S&P 500 Financials Sector SEC Filings — April 02, 2026

Across 50 SEC filings from the USA S&P 500 Financials stream (with cross-sector exposure including REITs, financial data providers, pharma/mining outliers), sentiment is mixed with 12 positive, 14 mixed, and 10 negative summaries; period-over-period trends reveal revenue growth averaging +18% YoY in outperformers like Pharming (+26.6% to $376M), Dynaresource (+25.7% to $58M), and FactSet (+7% to $611M Q), but sharp declines in underperformers like Airsculpt (-15.8% FY to $152M), LightInTheBox (-12.2% to $224M), and Lindsay (-16% Q2 to $158M). Capital allocation emphasizes buybacks (News Corp $1B program, FactSet $303M YTD, Lindsay $25M Q2, Oceaneering $40M) and dividends (Burford 6.25¢ final), signaling shareholder returns amid volatility; M&A/SPAC activity is robust with accretive deals like Kodiak's $587M DPS acquisition (+395MW capacity) and Crown Reserve's $1B EV Carvix combo ($80M PIPE). Forward-looking catalysts cluster in May 2026 AGMs (20+ filings, e.g., Sylvamo May15, Burford May13) and guidance reaffirms (ESAB, Sally Beauty FY26); debt actions improve liquidity (Terra exchange to 2029 notes, Transocean $358M retire/$0.75B 2026 plan, CareView maturity to Jun30). Portfolio implications: overweight accretive M&A/REIT restructurings, underweight going concerns (Mannatech, Algorhythm); sector shows resilience in financial metrics (e.g., FactSet op CF +28%) despite broader declines.

28 high priority22 medium50 total filings
·daily

S&P 500 Consumer Staples Sector SEC Filings — April 02, 2026

Across 50 filings from the USA S&P 500 Consumer Staples intelligence stream (though diverse sectors represented), proxy statements dominate (over 60%), signaling the onset of 2026 proxy season with annual meetings clustered in May-June 2026, emphasizing governance, director elections, auditor ratifications, and say-on-pay votes. Positive outliers include accretive M&A (Kodiak's $587M acquisition adding 395MW capacity, immediately EPS/DCF accretive), record performances (Morgan Stanley's $70.6B 2025 revenues, $10.21 EPS, 21.6% ROTCE; BlackRock ESG's 86% cumulative return since 2023 vs. 56% benchmark), and capital optimization (CVGI's $16M sale-leaseback delevering facility). Limited period-over-period data shows bullish trends like Cleveland-Cliffs' 43% safety incident reduction since 2020 and Diamond Hill's $25.9B AUM (led by Consumer Staples like Costco at $57M). No widespread margin compression or revenue declines; neutral sentiment prevails (70% of filings) with positive M&A/capital raises (10%). Consumer Staples exposure indirect via 13F top holding Costco ($57M, 57k shares). Implications: Low sector distress, focus on governance catalysts and M&A for alpha; monitor May meetings for votes.

27 high priority23 medium50 total filings
← All geographies